Skip to main content
PMC home page
Gut logoLink to Gut
. 1984 Jul;25(7):760–783. doi: 10.1136/gut.25.7.760

Macrophage activation, chronic inflammation and gastrointestinal disease.

A R Tanner, M J Arthur, R Wright
PMCID: PMC1432607  PMID: 6376293

Full text

PDF
763

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON A. C., SANDELIN K. Activation of lysosomal enzymes in virus-infected cells and its possible relationship to cytopathic effects. J Exp Med. 1963 Jun 1;117:879–887. doi: 10.1084/jem.117.6.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abraham R., Fabian R. J., Golberg L., Coulston F. Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology. 1974 Dec;67(6):1169–1181. [PubMed] [Google Scholar]
  3. Alitalo K., Hovi T., Vaheri A. Fibronectin is produced by human macrophages. J Exp Med. 1980 Mar 1;151(3):602–613. doi: 10.1084/jem.151.3.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ando M., Dannenberg A. M., Jr Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. IV. Macrophage turnover, lysosomal enzymes, and division in healing lesions. Lab Invest. 1972 Nov;27(5):466–472. [PubMed] [Google Scholar]
  6. Blackwell J. B. Cirrhosis resulting from repeated injections of antigen. J Pathol Bacteriol. 1965 Jul;90(1):245–257. doi: 10.1002/path.1700900127. [DOI] [PubMed] [Google Scholar]
  7. Bookman M. A., Bull D. M. Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease. Gastroenterology. 1979 Sep;77(3):503–510. [PubMed] [Google Scholar]
  8. Boumsell L., Meltzer M. S. Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages. J Immunol. 1975 Dec;115(6):1746–1748. [PubMed] [Google Scholar]
  9. Broxmeyer H. E., Smithyman A., Eger R. R., Meyers P. A., de Sousa M. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med. 1978 Oct 1;148(4):1052–1067. doi: 10.1084/jem.148.4.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Buermann C. W., Oronsky A. L., Horowitz M. I. Chondroitin sulfate-degrading enzymes in human polymorphonuclear leukocytes: characteristics and evidence for concerted mechanism. Arch Biochem Biophys. 1979 Mar;193(1):277–283. doi: 10.1016/0003-9861(79)90032-8. [DOI] [PubMed] [Google Scholar]
  11. Calderon J., Unanue E. R. Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature. 1975 Jan 31;253(5490):359–361. doi: 10.1038/253359a0. [DOI] [PubMed] [Google Scholar]
  12. Cardella C. J., Davies P., Allison A. C. Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature. 1974 Jan 4;247(5435):46–48. doi: 10.1038/247046a0. [DOI] [PubMed] [Google Scholar]
  13. Carp H., Janoff A. In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J Clin Invest. 1979 Apr;63(4):793–797. doi: 10.1172/JCI109364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chipman D. M., Sharon N. Mechanism of lysozyme action. Science. 1969 Aug 1;165(3892):454–465. doi: 10.1126/science.165.3892.454. [DOI] [PubMed] [Google Scholar]
  15. Christie G. H., Bomford R. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments. Cell Immunol. 1975 May;17(1):141–149. doi: 10.1016/s0008-8749(75)80014-1. [DOI] [PubMed] [Google Scholar]
  16. Cline M. J. Bactericidal Activity of Human Macrophages: Analysis of Factors Influencing the Killing of Listeria monocytogenes. Infect Immun. 1970 Aug;2(2):156–161. doi: 10.1128/iai.2.2.156-161.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cline M. J. Defective mononuclear phagocyte function in patients with myelomonocytic leukemia and in some patients with lymphoma. J Clin Invest. 1973 Sep;52(9):2185–2190. doi: 10.1172/JCI107403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cohen A. B., Gold W. M. Defense mechanisms of the lungs. Annu Rev Physiol. 1975;37:325–350. doi: 10.1146/annurev.ph.37.030175.001545. [DOI] [PubMed] [Google Scholar]
  19. Cohn Z. A., Fedorko M. E., Hirsch J. G. The in vitro differentiation of mononuclear phagocytes. V. The formation of macrophage lysosomes. J Exp Med. 1966 Apr 1;123(4):757–766. doi: 10.1084/jem.123.4.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Colman J. C., Morgan M. Y., Scheuer P. J., Sherlock S. Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial. Gut. 1980 Nov;21(11):965–969. doi: 10.1136/gut.21.11.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cox D. W., Smyth S. Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med. 1983 Feb;74(2):221–227. doi: 10.1016/0002-9343(83)90615-0. [DOI] [PubMed] [Google Scholar]
  22. Crofton R. W., Diesselhoff-den Dulk M. M., van Furth R. The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med. 1978 Jul 1;148(1):1–17. doi: 10.1084/jem.148.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. D'Amelio R., Rossi P., Le Moli S., Ricci R., Montano S., Pallone F. In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. Gut. 1981 Jul;22(7):566–570. doi: 10.1136/gut.22.7.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dannenberg A. M., Jr Macrophages in inflammation and infection. N Engl J Med. 1975 Sep 4;293(10):489–493. doi: 10.1056/NEJM197509042931010. [DOI] [PubMed] [Google Scholar]
  25. David J. R. Macrophage activation by lymphocyte mediators. Fed Proc. 1975 Jul;34(8):1730–1736. [PubMed] [Google Scholar]
  26. Davies P., Page R. C., Allison A. C. Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med. 1974 May 1;139(5):1262–1282. doi: 10.1084/jem.139.5.1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  28. Deimann W., Fahimi H. D. Hepatic granulomas induced by glucan. An ultrastructural and peroxidase-cytochemical study. Lab Invest. 1980 Aug;43(2):172–181. [PubMed] [Google Scholar]
  29. Deimann W., Fahimi H. D. The appearance of transition forms between monocytes and Kupffer cells in the liver of rats treated with glucan. A cytochemical and ultrastructural study. J Exp Med. 1979 Apr 1;149(4):883–897. doi: 10.1084/jem.149.4.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Diesselhoff-den Dulk M. M., Crofton R. W., van Furth R. Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology. 1979 May;37(1):7–14. [PMC free article] [PubMed] [Google Scholar]
  31. Doe W. F., Dorsman B. Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes. Clin Exp Immunol. 1982 Apr;48(1):256–260. [PMC free article] [PubMed] [Google Scholar]
  32. Drutz D. J., Cline M. J., Levy L. Leukocyte antimicrobial function in patients with leprosy. J Clin Invest. 1974 Feb;53(2):380–386. doi: 10.1172/JCI107570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Edwards R. L., Rickles F. R., Bobrove A. M. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood. 1979 Aug;54(2):359–370. [PubMed] [Google Scholar]
  34. FISHER E. R., FISHER B. Hepatic damage by reticuloendothelial interference. Arch Pathol. 1963 Feb;75:191–195. [PubMed] [Google Scholar]
  35. Ferluga J., Allison A. C. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet. 1978 Sep 16;2(8090):610–611. doi: 10.1016/s0140-6736(78)92828-3. [DOI] [PubMed] [Google Scholar]
  36. Fliedner T. M., Laeger F., Cronkite E. P. Zytokinetische Untersuchungen an menschlichen Blutmonozyten. Hamatol Bluttransfus. 1969;7:39–51. [PubMed] [Google Scholar]
  37. Friedland J., Setton C., Silverstein E. Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science. 1977 Jul 1;197(4298):64–65. doi: 10.1126/science.194311. [DOI] [PubMed] [Google Scholar]
  38. Fulenwider J. T., Sibley C., Stein S. F., Evatt B., Nordlinger B. M., Ivey G. L. Endotoxemia of cirrhosis: an observation not substantiated. Gastroenterology. 1980 May;78(5 Pt 1):1001–1004. [PubMed] [Google Scholar]
  39. Gale R. P., Feig S., Opelz G., Territo M., Young L., Sarna G., Fahey J., Cline M. J. Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA). Transplant Proc. 1976 Dec;8(4):611–616. [PubMed] [Google Scholar]
  40. Ganguly N. K., Kingham J. G., Lloyd B., Lloyd R. S., Price C. P., Triger D. R., Wright R. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet. 1978 May 20;1(8073):1073–1075. doi: 10.1016/s0140-6736(78)90917-0. [DOI] [PubMed] [Google Scholar]
  41. Gassmann A. E., van Furth R. The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction. Blood. 1975 Jul;46(1):51–64. [PubMed] [Google Scholar]
  42. Gebbers J. O., Otto H. F. Evidence for local immune complexes in ulcerative colitis. Acta Gastroenterol Belg. 1978 May-Jun;41(5-6):329–350. [PubMed] [Google Scholar]
  43. Geisow M. A carbohydrate signal for intracellular transit. Nature. 1981 Mar 5;290(5801):15–15. doi: 10.1038/290015a0. [DOI] [PubMed] [Google Scholar]
  44. Glass E. J., Kay A. B. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants. Clin Exp Immunol. 1980 Mar;39(3):768–775. [PMC free article] [PubMed] [Google Scholar]
  45. Goldberg A. R. Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production. Cell. 1974 Jun;2(2):95–102. doi: 10.1016/0092-8674(74)90097-x. [DOI] [PubMed] [Google Scholar]
  46. Golde D. W., Cline M. J. Identification of the colony-stimulating cell in human peripheral blood. J Clin Invest. 1972 Nov;51(11):2981–2983. doi: 10.1172/JCI107124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Golder J. P., Doe W. F. Isolation and preliminary characterization of human intestinal macrophages. Gastroenterology. 1983 Apr;84(4):795–802. [PubMed] [Google Scholar]
  48. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977 Dec 1;146(6):1719–1734. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Gordon L. I., Douglas S. D., Kay N. E., Yamada O., Osserman E. F., Jacob H. S. Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest. 1979 Jul;64(1):226–232. doi: 10.1172/JCI109443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Gordon L. I., Miller W. J., Branda R. F., Zanjani E. D., Jacob H. S. Regulation of erythroid colony formation by bone marrow macrophages. Blood. 1980 Jun;55(6):1047–1050. [PubMed] [Google Scholar]
  51. Gordon S., Newman W., Bloom B. Macrophage proteases and rheumatic diseases: regulation of plasminogen activator by thymus-derived lymphocytes. Agents Actions. 1978 Jan;8(1-2):19–26. doi: 10.1007/BF01972397. [DOI] [PubMed] [Google Scholar]
  52. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Gordon S., Unkeless J. C., Cohn Z. A. Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process. J Exp Med. 1974 Oct 1;140(4):995–1010. doi: 10.1084/jem.140.4.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Greenwald R. A., Moy W. W. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980 Apr;23(4):455–463. doi: 10.1002/art.1780230408. [DOI] [PubMed] [Google Scholar]
  55. Hassner A., Kletter Y., Shlag D., Yedvab M., Aronson M., Shibolet S. Impaired monocyte function in liver cirrhosis. Br Med J (Clin Res Ed) 1981 Apr 18;282(6272):1262–1263. doi: 10.1136/bmj.282.6272.1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hirata K., Kaneko A., Ogawa K., Hayasaka H., Onoé T. Effect of endotoxin on rat liver. Analysis of acid phosphatase isozymes in the liver of normal and endotoxin-treated rats. Lab Invest. 1980 Aug;43(2):165–171. [PubMed] [Google Scholar]
  57. Hocking W. G., Golde D. W. The pulmonary-alveolar macrophage (first of two parts). N Engl J Med. 1979 Sep 13;301(11):580–587. doi: 10.1056/NEJM197909133011104. [DOI] [PubMed] [Google Scholar]
  58. Hogg N. Human monocytes are associated with the formation of fibrin. J Exp Med. 1983 Feb 1;157(2):473–485. doi: 10.1084/jem.157.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Holdstock G., Hammond P. G., Iles S., Smith J. L., Tanner A. R., Wright R. Activation of monocytes by portal serum and its relationship to immunoglobulin, immune complex and endotoxin content. Liver. 1982 Sep;2(3):222–229. doi: 10.1111/j.1600-0676.1982.tb00200.x. [DOI] [PubMed] [Google Scholar]
  60. Hopper K. E., Wood P. R., Nelson D. S. Macrophage heterogeneity. Vox Sang. 1979;36(5):257–274. doi: 10.1111/j.1423-0410.1979.tb04434.x. [DOI] [PubMed] [Google Scholar]
  61. Hovi T., Mosher D., Vaheri A. Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med. 1977 Jun 1;145(6):1580–1589. doi: 10.1084/jem.145.6.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Isaacson P., Jones D. B., Millward-Sadler G. H., Judd M. A., Payne S. Alpha-1-antitrypsin in human macrophages. J Clin Pathol. 1981 Sep;34(9):982–990. doi: 10.1136/jcp.34.9.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. JANOFF A., WEISSMANN G., ZWEIOFACH B. W., THOMAS L. Pathogenesis of experimental shock. IV. Studies on lysosomes in normal and tolerant animals subjected to lethal trauma and endotoxemia. J Exp Med. 1962 Oct 1;116:451–466. doi: 10.1084/jem.116.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Janoff A., Carp H. Proteases, antiproteases, and oxidants: pathways of tissue injury during inflammation. Monogr Pathol. 1982;(23):62–82. [PubMed] [Google Scholar]
  65. Johnson K. J., Ward P. A. Role of oxygen metabolites in immune complex injury of lung. J Immunol. 1981 Jun;126(6):2365–2369. [PubMed] [Google Scholar]
  66. Johnston R. B., Jr, Godzik C. A., Cohn Z. A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978 Jul 1;148(1):115–127. doi: 10.1084/jem.148.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Karnovsky M. L., Lazdins J. K. Biochemical criteria for activated macrophages. J Immunol. 1978 Sep;121(3):809–813. [PubMed] [Google Scholar]
  68. Kent G., Gay S., Inouye T., Bahu R., Minick O. T., Popper H. Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3719–3722. doi: 10.1073/pnas.73.10.3719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kinsky R. G., Christie G. H., Elson J., Howard J. G. Extra-hepatic derivation of Kupffer cells during oestrogenic stimulation of parabiosed mice. Br J Exp Pathol. 1969 Oct;50(5):438–447. [PMC free article] [PubMed] [Google Scholar]
  70. Klasen E. C., Biemond I., Weterman I. T. alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands. Gut. 1980 Oct;21(10):840–842. doi: 10.1136/gut.21.10.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Koren H. S., Meltzer M. S., Adams D. O. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG. J Immunol. 1981 Mar;126(3):1013–1015. [PubMed] [Google Scholar]
  72. Kueppers F., Bearn A. G. A possible experimental approach to the association of hereditary alpha-1-antitrypsin deficiency and pulmonary emphysema. Proc Soc Exp Biol Med. 1966 Apr;121(4):1207–1209. doi: 10.3181/00379727-121-31006. [DOI] [PubMed] [Google Scholar]
  73. Kurkinen M., Vaheri A., Roberts P. J., Stenman S. Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest. 1980 Jul;43(1):47–51. [PubMed] [Google Scholar]
  74. Kurland J. I., Bockman R. S., Broxmeyer H. E., Moore M. A. Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science. 1978 Feb 3;199(4328):552–555. doi: 10.1126/science.304600. [DOI] [PubMed] [Google Scholar]
  75. Lieberman J. Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med. 1969 Aug 7;281(6):279–284. doi: 10.1056/NEJM196908072810601. [DOI] [PubMed] [Google Scholar]
  76. Ligumsky M., Karmeli F., Sharon P., Zor U., Cohen F., Rachmilewitz D. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. 1981 Sep;81(3):444–449. [PubMed] [Google Scholar]
  77. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. MacDermott R. P., Franklin G. O., Jenkins K. M., Kodner I. J., Nash G. S., Weinrieb I. J. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities. Gastroenterology. 1980 Jan;78(1):47–56. [PubMed] [Google Scholar]
  79. Maderazo E. C., Ward P. A., Quintiliani R. Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med. 1975 Apr;85(4):621–630. [PubMed] [Google Scholar]
  80. Maruta H., Mizuno D. Selective recognition of various erythrocytes in endocytosis by mouse peritoneal macrophages. Nat New Biol. 1971 Dec 22;234(51):246–248. doi: 10.1038/newbio234246a0. [DOI] [PubMed] [Google Scholar]
  81. Matheson N. R., Wong P. S., Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun. 1979 May 28;88(2):402–409. doi: 10.1016/0006-291x(79)92062-x. [DOI] [PubMed] [Google Scholar]
  82. Mee A. S., Berney J., Jewell D. P. Monocytes in inflammatory bowel disease: absolute monocyte counts. J Clin Pathol. 1980 Oct;33(10):917–920. doi: 10.1136/jcp.33.10.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Mee A. S., Jewell D. P. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity. Clin Sci (Lond) 1980 Apr;58(4):295–300. doi: 10.1042/cs0580295. [DOI] [PubMed] [Google Scholar]
  84. Mee A. S., Nuttall L., Potter B. J., Jewell D. P. Studies on monocytes in inflammatory bowel disease: factors influencing monocyte lysosomal enzyme activity. Clin Exp Immunol. 1980 Mar;39(3):785–791. [PMC free article] [PubMed] [Google Scholar]
  85. Mee A. S., Szawatakowski M., Jewell D. P. Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. J Clin Pathol. 1980 Oct;33(10):921–925. doi: 10.1136/jcp.33.10.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Meuret G., Bitzi A., Hammer B. Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology. 1978 Mar;74(3):501–503. [PubMed] [Google Scholar]
  87. Meuret G., Hoffmann G. Monocyte kinetic studies in normal and disease states. Br J Haematol. 1973 Mar;24(3):275–285. doi: 10.1111/j.1365-2141.1973.tb01652.x. [DOI] [PubMed] [Google Scholar]
  88. Moráin C. O., Segal A. A., Walker D., Levi A. J. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut. 1981 Oct;22(10):817–822. doi: 10.1136/gut.22.10.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Neumann C., Sorg C. Immune interferon. I. Production by lymphokine-activated murine macrophages. Eur J Immunol. 1977 Oct;7(10):719–725. doi: 10.1002/eji.1830071014. [DOI] [PubMed] [Google Scholar]
  90. Nogueira N., Gordon S., Cohn Z. Trypanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes. J Exp Med. 1977 Jul 1;146(1):172–183. doi: 10.1084/jem.146.1.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. North R. J. The concept of the activated macrophage. J Immunol. 1978 Sep;121(3):806–809. [PMC free article] [PubMed] [Google Scholar]
  92. Ogmundsdóttir H. M., Weir D. M. Mechanisms of macrophage activation. Clin Exp Immunol. 1980 May;40(2):223–234. [PMC free article] [PubMed] [Google Scholar]
  93. Otto H. F., Gebbers J. O. Electron microscopic, ultracytochemical and immunohistological observations in Crohn's disease of the ileum and colon. Virchows Arch A Pathol Anat Histol. 1981;391(2):189–205. doi: 10.1007/BF00437596. [DOI] [PubMed] [Google Scholar]
  94. PAGLIARO L., GIGLIO F., LEMOLI S., CATANIA A., CITARRELLA P. BETA-GLUCURONIDASE AND ACID PHOSPHATASE ACTIVITIES OF LYSOSOMAL PREPARATIONS FROM HUMAN LIVER TISSUE OBTAINED BY NEEDLE BIOPSY FROM SUBJECTS WITH ACUTE HEPATITIS AND CIRRHOSIS. J Lab Clin Med. 1964 Jun;63:977–985. [PubMed] [Google Scholar]
  95. PINEDA E. P., GOLDBARG J. A., BANKS B. M., RUTENBURG A. M. The significance of serum beta-glucuronidase activity in patients with liver disease; a preliminary report. Gastroenterology. 1959 Feb;36(2):202–213. [PubMed] [Google Scholar]
  96. Page R. C., Davies P., Allison A. C. Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc. 1974 May;15(5):413–438. [PubMed] [Google Scholar]
  97. Pantalone R. M., Page R. C. Lymphokine-induced production and release of lysosomal enzymes by macrophages. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2091–2094. doi: 10.1073/pnas.72.6.2091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Parks D. A., Bulkley G. B., Granger D. N., Hamilton S. R., McCord J. M. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology. 1982 Jan;82(1):9–15. [PubMed] [Google Scholar]
  99. Picker L. J., Raff H. V., Goldyne M. E., Stobo J. D. Metabolic heterogeneity among human monocytes and its modulation by PGE2. J Immunol. 1980 Jun;124(6):2557–2562. [PubMed] [Google Scholar]
  100. Polverini P. J., Cotran P. S., Gimbrone M. A., Jr, Unanue E. R. Activated macrophages induce vascular proliferation. Nature. 1977 Oct 27;269(5631):804–806. doi: 10.1038/269804a0. [DOI] [PubMed] [Google Scholar]
  101. Prytz H., Holst-Christensen J., Korner B., Liehr H. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol. 1976;11(8):857–863. [PubMed] [Google Scholar]
  102. Quesenberry P., Levitt L. Hematopoietic stem cells (second of three parts). N Engl J Med. 1979 Oct 11;301(15):819–823. doi: 10.1056/NEJM197910113011505. [DOI] [PubMed] [Google Scholar]
  103. Rachmilewitz D., Ligumsky M., Haimovitz A., Treves A. J. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. Gastroenterology. 1982 Apr;82(4):673–679. [PubMed] [Google Scholar]
  104. Rachmilewitz D., Ligumsky M., Rachmilewitz B., Rachmilewitz M., Tarcic N., Schlesinger M. Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel. Gastroenterology. 1980 Jan;78(1):43–46. [PubMed] [Google Scholar]
  105. Reiner R. G., Tanner A. R., Keyhani A. H., Wright R. A comparative study of lysosomal enzyme activity in monocytes and Kupffer cells isolated simultaneously in a rat model of liver injury. Clin Exp Immunol. 1981 Feb;43(2):376–380. [PMC free article] [PubMed] [Google Scholar]
  106. Rhodes J. M., Bartholomew T. C., Jewell D. P. Inhibition of leucocyte motility by drugs used in ulcerative colitis. Gut. 1981 Aug;22(8):642–647. doi: 10.1136/gut.22.8.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Rhodes J. M., Jewell D. P. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis. Gut. 1983 Jan;24(1):73–77. doi: 10.1136/gut.24.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Rhodes J. M., Potter B. J., Brown D. J., Jewell D. P. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology. 1982 Jun;82(6):1327–1334. [PubMed] [Google Scholar]
  109. Roberts N. J., Jr, Douglas R. G., Jr, Simons R. M., Diamond M. E. Virus-induced interferon production by human macrophages. J Immunol. 1979 Jul;123(1):365–369. [PubMed] [Google Scholar]
  110. Rodey G. E., Park B. H., Windhorst D. B., Good R. A. Defective bactericidal activity of monocytes in fatal granulomatous disease. Blood. 1969 Jun;33(6):813–820. [PubMed] [Google Scholar]
  111. Rogoff T. M., Lipsky P. E. Role of the Kupffer cells in local and systemic immune responses. Gastroenterology. 1981 Apr;80(4):854–860. [PubMed] [Google Scholar]
  112. Roser B. The distribution of intravenously injected Kupffer cellsin the mouse. J Reticuloendothel Soc. 1968 Oct;5(5):455–471. [PubMed] [Google Scholar]
  113. Rouzer C. A., Scott W. A., Hamill A. L., Liu F. T., Katz D. H., Cohn Z. A. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med. 1982 Oct 1;156(4):1077–1086. doi: 10.1084/jem.156.4.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Ruco L. P., Meltzer M. S. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. J Immunol. 1978 Nov;121(5):2035–2042. [PubMed] [Google Scholar]
  115. Ruco L. P., Meltzer M. S. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. J Immunol. 1978 Mar;120(3):1054–1062. [PubMed] [Google Scholar]
  116. SAITO K., SUTER E. LYSOSOMAL ACID HYDROLASES IN MICE INFECTED WITH BCG. J Exp Med. 1965 May 1;121:727–738. doi: 10.1084/jem.121.5.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Saba T. M. Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med. 1970 Dec;126(6):1031–1052. [PubMed] [Google Scholar]
  118. Schmitt E., Meuret G., Stix L. Monocyte recruitment in tuberculosis and sarcoidosis. Br J Haematol. 1977 Jan;35(1):11–17. doi: 10.1111/j.1365-2141.1977.tb00557.x. [DOI] [PubMed] [Google Scholar]
  119. Schnyder J., Baggiolini M. Role of phagocytosis in the activation of macrophages. J Exp Med. 1978 Dec 1;148(6):1449–1457. doi: 10.1084/jem.148.6.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Schorlemmer H. U., Allison A. C. Effects of activated complement components on enzyme secretion by macrophages. Immunology. 1976 Nov;31(5):781–788. [PMC free article] [PubMed] [Google Scholar]
  121. Schorlemmer H. U., Davies P., Hylton W., Gugig M., Allison A. C. The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation. Br J Exp Pathol. 1977 Jun;58(3):315–326. [PMC free article] [PubMed] [Google Scholar]
  122. Schultz R. M., Papamatheakis J. D., Chirigos M. A. Interferon: an inducer of macrophage activation by polyanions. Science. 1977 Aug 12;197(4304):674–676. doi: 10.1126/science.877584. [DOI] [PubMed] [Google Scholar]
  123. Scott W. A., Zrike J. M., Hamill A. L., Kempe J., Cohn Z. A. Regulation of arachidonic acid metabolites in macrophages. J Exp Med. 1980 Aug 1;152(2):324–335. doi: 10.1084/jem.152.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Segal A. W., Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet. 1976 Jul 31;2(7979):219–221. doi: 10.1016/s0140-6736(76)91024-2. [DOI] [PubMed] [Google Scholar]
  125. Shahar A., Kletter Y., Aronson M. Granuloma formation in cryptococcosis. Isr J Med Sci. 1969 Nov-Dec;5(6):1164–1172. [PubMed] [Google Scholar]
  126. Sharon P., Ligumsky M., Rachmilewitz D., Zor U. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 1978 Oct;75(4):638–640. [PubMed] [Google Scholar]
  127. Sherlock S. Patterns of hepatocyte injury in man. Lancet. 1982 Apr 3;1(8275):782–786. doi: 10.1016/s0140-6736(82)91822-0. [DOI] [PubMed] [Google Scholar]
  128. Simon R. H., Scoggin C. H., Patterson D. Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J Biol Chem. 1981 Jul 25;256(14):7181–7186. [PubMed] [Google Scholar]
  129. Smith P. R., Dawson D. J., Swan C. H. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut. 1979 Sep;20(9):802–805. doi: 10.1136/gut.20.9.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
  131. Sonnenfeld G., Mandel A. D., Merigan T. C. In vitro production and cellular origin of murine type II interferon. Immunology. 1979 Apr;36(4):883–890. [PMC free article] [PubMed] [Google Scholar]
  132. Souhami R. L., Bradfield J. W. The recovery of hepatic phagocytosis after blockade of Kupffer cells. J Reticuloendothel Soc. 1974 Aug;16(2):75–86. [PubMed] [Google Scholar]
  133. Stossel T. P. The mechanism of phagocytosis. J Reticuloendothel Soc. 1976 Apr;19(4):237–245. [PubMed] [Google Scholar]
  134. Tanner A. R., Keyhani A. H., Wright R. The influence of endotoxin in vitro on hepatic macrophage lysosomal enzyme release in different rat models of hepatic injury. Liver. 1983 Jun;3(3):151–160. doi: 10.1111/j.1600-0676.1983.tb00864.x. [DOI] [PubMed] [Google Scholar]
  135. Tanner A., Keyhani A., Reiner R., Holdstock G., Wright R. Proteolytic enzymes released by liver macrophages may promote hepatic injury in a rat model of hepatic damage. Gastroenterology. 1981 Apr;80(4):647–654. [PubMed] [Google Scholar]
  136. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  137. Unanue E. R. Secretory function of mononuclear phagocytes: a review. Am J Pathol. 1976 May;83(2):396–418. [PMC free article] [PubMed] [Google Scholar]
  138. Unanue E. R. The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol. 1981;31:1–136. doi: 10.1016/s0065-2776(08)60919-0. [DOI] [PubMed] [Google Scholar]
  139. Unkeless J. C., Gordon S., Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974 Apr 1;139(4):834–850. doi: 10.1084/jem.139.4.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Van Epps D. E., Strickland R. G., Williams R. C., Jr Inhibitors of leukocyte chemotaxis in alcoholic liver disease. Am J Med. 1975 Aug;59(2):200–207. doi: 10.1016/0002-9343(75)90354-x. [DOI] [PubMed] [Google Scholar]
  141. Volkman A. Disparity in origin of mononuclear phagocyte populations. J Reticuloendothel Soc. 1976 Apr;19(4):249–268. [PubMed] [Google Scholar]
  142. WEISSMANN G. LYSOSOMES, AUTOIMMUNE PHENOMENA, AND DISEASES OF CONNECTIVE TISSUE. Lancet. 1964 Dec 26;2(7374):1373–1375. doi: 10.1016/s0140-6736(64)91163-8. [DOI] [PubMed] [Google Scholar]
  143. Wandall J. H., Binder V. Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro. Gut. 1982 Mar;23(3):173–180. doi: 10.1136/gut.23.3.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Wandall J. H., Binder V. Leucocyte function in ulcerative colitis. Quantitative leucocyte mobilisation to skin windows and in vitro function of blood leucocytes. Gut. 1982 Sep;23(9):758–765. doi: 10.1136/gut.23.9.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Ward M. The pathogenesis of Crohn's disease. Lancet. 1977 Oct 29;2(8044):903–905. doi: 10.1016/s0140-6736(77)90835-2. [DOI] [PubMed] [Google Scholar]
  146. Wardle N., Anderson A., James O. Kupffer cell phagocytosis in relation to BSP clearance in liver and inflammatory bowel diseases. Dig Dis Sci. 1980 Jun;25(6):414–419. doi: 10.1007/BF01395504. [DOI] [PubMed] [Google Scholar]
  147. Warr G. W., Sljivić V. S. Origin and division of liver macrophages during stimulation of the mononuclear phagocyte system. Cell Tissue Kinet. 1974 Nov;7(6):559–565. doi: 10.1111/j.1365-2184.1974.tb00439.x. [DOI] [PubMed] [Google Scholar]
  148. Webel M. L., Ritts R. E., Jr, Taswell H. F., Danadio J. V., Jr, Woods J. E. Cellular immunity after intravenous administration of methylprednisolone. J Lab Clin Med. 1974 Mar;83(3):383–392. [PubMed] [Google Scholar]
  149. Weissmann G., Smolen J. E., Korchak H. M. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med. 1980 Jul 3;303(1):27–34. doi: 10.1056/NEJM198007033030109. [DOI] [PubMed] [Google Scholar]
  150. Werb Z., Banda M. J., Jones P. A. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med. 1980 Nov 1;152(5):1340–1357. doi: 10.1084/jem.152.5.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Werb Z. Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med. 1978 Jun 1;147(6):1695–1712. doi: 10.1084/jem.147.6.1695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Werb Z., Gordon S. Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med. 1975 Aug 1;142(2):361–377. doi: 10.1084/jem.142.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Werb Z., Gordon S. Secretion of a specific collagenase by stimulated macrophages. J Exp Med. 1975 Aug 1;142(2):346–360. doi: 10.1084/jem.142.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Whitelaw D. M. Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet. 1972 Jul;5(4):311–317. doi: 10.1111/j.1365-2184.1972.tb00369.x. [DOI] [PubMed] [Google Scholar]
  155. Whorwell P. J., Bennett P., Tanner A. R., Wright R. Monocyte function in Crohn's disease and ulcerative colitis. Digestion. 1981;22(5):271–275. doi: 10.1159/000198668. [DOI] [PubMed] [Google Scholar]
  156. Williams G. M., Bermudez E., San R. H., Goldblatt P. J., Laspia M. F. Rat hepatocyte primary cultures. IV. Maintenance in defined medium and the role of production of plasminogen activator and other proteases. In Vitro. 1978 Oct;14(10):824–837. doi: 10.1007/BF02616152. [DOI] [PubMed] [Google Scholar]
  157. Wing E. J., Gardner I. D., Ryning F. W., Remington J. S. Dissociation of effector functions in populations of activated macrophages. Nature. 1977 Aug 18;268(5621):642–644. doi: 10.1038/268642a0. [DOI] [PubMed] [Google Scholar]
  158. Wyatt H. V., Colten H. R., Borsos T. Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components. J Immunol. 1972 Jun;108(6):1609–1614. [PubMed] [Google Scholar]
  159. van Furth R., Gassmann A. E., Diesselhoff-Den Dulk M. M. The effect of azathioprine (Imuran) on the cell cycle of promonocytes and the production of monocytes in the bone marrow. J Exp Med. 1975 Mar 1;141(3):531–546. doi: 10.1084/jem.141.3.531. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES